The Organic Synthesis Facility supports the Cancer Center's research activities in environmental carcinogenesis, and chemoprevention, and the identification of host factors of etiologic significance by providing chemically pure compounds for model assays, as reference materials, and as internal standards. It is a dedicated resource occupying 900 sq. ft. in Unit 1 and 447 sq. ft on the lower level of the NDI in Valhalla. The CCSG- supported staff are the Facility Head, Shantu Amin, Ph.D. and one organic chemist, Jacek Krzeminski, Ph.D. The Facility supports the Cancer Center's research activities in environmental carcinogenesis, and chemoprevention, and the identification of host factors of etiologic significance by providing chemically pure compounds for model assays, as reference materials, and as internal standards. Requested compounds are furnished to AHFCC's investigators in compounds is ensured by state-of-the-art technology, including HPLC, GC-MS, TLC, UV, IR, FTIR, MS, and NMR. The scientists in the facility are highly experienced in developing efficient synthetic routes for cold and radioisotope-labeled polynuclear aromatic hydrocarbons, tobacco-specific nitrosamines, and other environmental and nutritional carcinogens as well as their metabolites, and their DNA and protein adducts. The Facility's dedicated Carcinogen Synthesis Laboratory is equipped with high pressure liquid chromatographs including one instrument with a beta- flo-one model IC radioactivity detector, and with a medium pressure liquid chromatograph. These instruments enable the analysis and purification of starting materials, intermediates, and end products. The laboratory has hoods with glove box, a walk-in hood as required by regulatory statutes, and a special photolysis set-up. The dedicated selenium laboratory, in which chemoprevention agents are prepared, has a special exhaust system in compliance with safety regulations pertaining to these chemicals. The dedicated Synthesis Laboratory for intermediates, nucleoside markers, and chemopreventive agents is equipped with a photolysis set-up. HPLC with photo diode array detector, and two working hoods with a 24-hour exhaust system. Radiolabeled syntheses are carried out in another dedicated laboratory that is accessed only upon approval and is also supervised by the AHFCC's Safety Officer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA017613-26
Application #
6413601
Study Section
Project Start
2001-01-26
Project End
2001-11-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
26
Fiscal Year
2001
Total Cost
$242,857
Indirect Cost
Name
Institute for Cancer Prevention
Department
Type
DUNS #
City
Valhalla
State
NY
Country
United States
Zip Code
10595
Rennert, Gad; Kremer, Ran; Rennert, Hedy S et al. (2015) Lower lung cancer rates in Jewish smokers in Israel and the USA. Int J Cancer 137:2155-62
Beyea, Jan; Stellman, Steven D; Teitelbaum, Susan et al. (2013) Imputation method for lifetime exposure assessment in air pollution epidemiologic studies. Environ Health 12:62
Boffetta, Paolo; Jayaprakash, Vijayvel; Yang, Ping et al. (2011) Tobacco smoking as a risk factor of bronchioloalveolar carcinoma of the lung: pooled analysis of seven case-control studies in the International Lung Cancer Consortium (ILCCO). Cancer Causes Control 22:73-9
Farooq, Umar; Joshi, Monika; Nookala, Vinod et al. (2010) Self-reported exposure to pesticides in residential settings and risk of breast cancer: a case-control study. Environ Health 9:30
Muscat, Joshua E; Stellman, Steven D; Caraballo, Ralph S et al. (2009) Time to first cigarette after waking predicts cotinine levels. Cancer Epidemiol Biomarkers Prev 18:3415-20
Stellman, Steven D; Djordjevic, Mirjana V (2009) Monitoring the tobacco use epidemic II: The agent: Current and emerging tobacco products. Prev Med 48:S11-5
Watanabe, Karen H; Djordjevic, Mirjana V; Stellman, Steven D et al. (2009) Incremental lifetime cancer risks computed for benzo[a]pyrene and two tobacco-specific N-nitrosamines in mainstream cigarette smoke compared with lung cancer risks derived from epidemiologic data. Regul Toxicol Pharmacol 55:123-33
Stellman, Steven D (2006) Ernst Wynder: a remembrance. Prev Med 43:239-45
El-Bayoumy, Karam; Sinha, Raghu (2004) Mechanisms of mammary cancer chemoprevention by organoselenium compounds. Mutat Res 551:181-97
Boyiri, Telih; Guttenplan, Joseph; Khmelnitsky, Michael et al. (2004) Mammary carcinogenesis and molecular analysis of in vivo cII gene mutations in the mammary tissue of female transgenic rats treated with the environmental pollutant 6-nitrochrysene. Carcinogenesis 25:637-43

Showing the most recent 10 out of 27 publications